Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis
Clinical trial NCT02776033 · COMPLETED
Trial details
- NCT number
- NCT02776033
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2018-01-04
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.